Mon, August 15, 2022

Matthew Harrison Maintained (TSVT) at Buy with Decreased Target to $27 on, Aug 15th, 2022

Matthew Harrison of Morgan Stanley, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $28 to $27 on, Aug 15th, 2022.

Matthew has made no other calls on TSVT in the last 4 months.



There is 1 other peer that has a rating on TSVT. Out of the 1 peers that are also analyzing TSVT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $26 on, Monday, May 2nd, 2022